Insider Transactions in Q4 2022 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.04%
|
$3,500
$7.65 P/Share
|
|
Nov 30
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.45 P/Share
|
|
Nov 29
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.45 P/Share
|
|
Nov 28
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.4 P/Share
|
|
Nov 25
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.38 P/Share
|
|
Nov 18
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$3,500
$7.23 P/Share
|
|
Nov 17
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
250
+0.01%
|
$1,750
$7.24 P/Share
|
|
Nov 17
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.2 P/Share
|
|
Nov 16
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
150
+0.01%
|
$1,050
$7.1 P/Share
|
|
Nov 10
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.03%
|
$7,000
$7.07 P/Share
|